3.6. MDA-MB-231-Derived EVs Carrying miR-887-3p Targeted BTBD7 and Activated the Notch1/Hes1 Signaling Pathway to Promote BC Cell Drug Resistance. This evidence concerns the gene BTBD7 and breast cancer.